Companies Dominating the Sepsis Diagnostics Landscape
- BioMérieux SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Becton, Dickinson and Company
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche AG
- Danaher Corporation (Beckman Coulter, Inc.)
- Cepheid
- Beckman Coulter, Inc.
- Amara Health Analytics
- Wolters Kluwer N.V.
- Cerner Corp.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Sepsis Diagnostics Market in 2025 is evaluated at USD 2.74 billion.
The global market size was over USD 2.5 billion in 2024 and is anticipated to witness a CAGR of around 12%, crossing USD 10.91 billion revenue by 2037.
North America is estimated to garner USD 4.25 billion by 2037, attributed to developed healthcare infrastructure and the increasing incidence of sepsis and infectious diseases.
The major players in the market include BioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter, Inc.), Cepheid, Beckman Coulter, Inc., Amara Health Analytics, Wolters Kluwer N.V., Cerner Corp.
